CLINICAL OUTCOMES AND HOSPITAL COSTS ASSOCIATED WITH EMPIRICAL TREATMENT OF HOSPITAL-ACQUIRED PNEUMONIA WITH VANCOMYCIN OR LINEZOLID IN A CHINESE TERTIARY CARE HOSPITAL: A RETROSPECTIVE COHORT STUDY

被引：0

作者：

Yang, Y. ^{[1
]}

Song, Y. ^{[2
]}

Chen, W. ^{[3
]}

Liu, W. ^{[4
]}

Wang, K. ^{[4
,6
]}

Li, X. ^{[5
]}

Wang, K. ^{[4
,6
]}

Papadimitropoulos, M. ^{[7
]}

Montgomery, W. ^{[8
]}

机构：

[1] Eli Lilly Suzhou Pharmaceut Co Ltd, Shanghai, Peoples R China

[2] Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai 200433, Peoples R China

[3] Univ Toronto, Toronto, ON, Canada

[4] Eli Lilly Suzhou Pharmaceut Co Ltd, Shanghai Branch, Shanghai, Peoples R China

[5] VitalStrateg Res Inst, Shanghai, Peoples R China

[6] Eli Lilly Suzhou Pharmaceut Co Ltd, Shanghai, Peoples R China

[7] Eli Lilly Canada, Toronto, ON, Canada

[8] Eli Lilly Australia Pty Ltd, West Ryde, Australia

来源：

关键词：

D O I：

10.1016/j.jval.2014.08.514

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PIN14

引用

页码：A804 / A805

页数：2